TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR
TEVA CANADA LIMITED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR in Canada?
Yes. TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 300MG 200MG 600MG has an active shortage reported to Health Canada (last updated January 23, 2025).
Why is TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02393549
Strength
300MG 200MG 600MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE EFAVIRENZ
Tier
Unrated
Last Updated
2025-01-23
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
750MG · DIN 02247341
500MG · DIN 02247340
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
300MG · DIN 02370654